IP-6 infringement claims
This article was originally published in The Tan Sheet
Enzymatic Therapy seeks preliminary injunctions against, and damages from, five dietary supplement companies for alleged patent infringement in their marketing and selling of IP-6 products. Green Bay, Wis.-based Enzymatic licenses the '833 patent from Abulkalam Shamsuddin, MD, PhD. The two parties filed suit Oct. 20 in Baltimore, Md. federal court against Solaray, Nutraceutical International, BNG Enterprises, Lifesource Naturals and Water Pure doing business as Purity Products for patent and copyright infringement, unfair competition and invasion of privacy. A similar lawsuit against Jarrow Formulas was voluntarily dismissed Nov. 2. Enzymatic's Cell Forte with IP-6 & Inositol, promoted as enhancing "natural killer cell activity," is covered by the '833 patent
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: